ImmunoPrecise Antibodies (IPA) Institutional Ownership $0.44 0.00 (-1.02%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$0.44 +0.00 (+0.46%) As of 08:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$194.92KNumber ofInstitutional Sellers(last 12 months)0 Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407% 8/9/2024Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243% 1/29/2024Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% 1/31/2023Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 10/21/2022Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% 2/19/2021JPMorgan Chase & Co.19,505$292K0.0%N/A0.116% (Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($996K), Bank of Montreal Can ($668K), and Renaissance Technologies LLC ($65K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($604.39K), Bank of Montreal Can ($208.11K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 852,811 shares in the last 24 months. This purchase volume represents approximately $1.51M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 31,802 shares in the last 24 months. This volume of shares sold represents approximately $58.20K in transactions. Related Companies CytomX Therapeutics Major Shareholders Skye Bioscience Major Shareholders PDS Biotechnology Major Shareholders Applied Therapeutics Major Shareholders Gain Therapeutics Major Shareholders Medicus Pharma Major Shareholders BeyondSpring Major Shareholders Kronos Bio Major Shareholders Precision BioSciences Major Shareholders Immix Biopharma Major Shareholders This page (NASDAQ:IPA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.